Bell Investment Advisors’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-15
Closed -$697 2025
2023
Q2
$697 Buy
+15
New +$518 ﹤0.01% 1693

Bell Investment Advisors's DICE Position: Q3 2023 in Review

Bell Investment Advisors sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 15 shares — an estimated $697 sold.

Bell Investment Advisors first reported a position in DICE in Q2 2023 and held it in 1 quarter. The position peaked at $697 in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

  • Bell Investment Advisors reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Bell Investment Advisors sold 15 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $697.
  • Bell Investment Advisors first reported a position in DICE Therapeutics, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
  • Bell Investment Advisors's DICE Therapeutics, Inc. Common Stock position peaked at $697 in Q2 2023.
  • 0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Bell Investment Advisors's 13F filing for Q3 2023, filed 8 Nov 2023.